GURUFOCUS.COM » STOCK LIST » USA » NYSE » Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) » Definitions » EV-to-EBITDA
Switch to:

Biohaven Pharmaceutical Holding Co EV-to-EBITDA

: -15.22 (As of Today)
View and export this data going back to 2017. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Biohaven Pharmaceutical Holding Co's enterprise value is $11,042.1 Mil. Biohaven Pharmaceutical Holding Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $-725.4 Mil. Therefore, Biohaven Pharmaceutical Holding Co's EV-to-EBITDA for today is -15.22.

The historical rank and industry rank for Biohaven Pharmaceutical Holding Co's EV-to-EBITDA or its related term are showing as below:

BHVN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -20.12   Med: -8.72   Max: -2.04
Current: -15.22

During the past 7 years, the highest EV-to-EBITDA of Biohaven Pharmaceutical Holding Co was -2.04. The lowest was -20.12. And the median was -8.72.

BHVN's EV-to-EBITDA is ranked worse than
100% of 542 companies
in the Biotechnology industry
Industry Median: 3.50 vs BHVN: -15.22

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2022-10-02), Biohaven Pharmaceutical Holding Co's stock price is $151.17. Biohaven Pharmaceutical Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-14.820. Therefore, Biohaven Pharmaceutical Holding Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Biohaven Pharmaceutical Holding Co EV-to-EBITDA Historical Data

The historical data trend for Biohaven Pharmaceutical Holding Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohaven Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBITDA
Premium Member Only Premium Member Only -6.67 -6.00 -5.19 -7.76 -13.95

Biohaven Pharmaceutical Holding Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.48 -12.97 -13.95 -16.70 -14.57

Competitive Comparison

For the Biotechnology subindustry, Biohaven Pharmaceutical Holding Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biohaven Pharmaceutical Holding Co EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Biohaven Pharmaceutical Holding Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biohaven Pharmaceutical Holding Co's EV-to-EBITDA falls into.



Biohaven Pharmaceutical Holding Co EV-to-EBITDA Calculation

Biohaven Pharmaceutical Holding Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=11042.075/-725.395
=-15.22

Biohaven Pharmaceutical Holding Co's current Enterprise Value is $11,042.1 Mil.
Biohaven Pharmaceutical Holding Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-725.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohaven Pharmaceutical Holding Co  (NYSE:BHVN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biohaven Pharmaceutical Holding Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=151.17/-14.820
=At Loss

Biohaven Pharmaceutical Holding Co's share price for today is $151.17.
Biohaven Pharmaceutical Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.820.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Biohaven Pharmaceutical Holding Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biohaven Pharmaceutical Holding Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohaven Pharmaceutical Holding Co Business Description

Biohaven Pharmaceutical Holding Co logo
Traded in Other Exchanges
Address
C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, USA, 06510
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Executives
Antonijevic Irina director 215 CHURCH STREET NEW HAVEN CT 06510
Buten Matthew officer: Officer 215 CHURCH STREET NEW HAVEN CT 06510
Clark George C. officer: VP, Chief Accounting Officer 215 CHURCH STREET NEW HAVEN CT 06510
Mehta Kishan director 540 WEST 49TH STREET UNIT# PH1N NEW YORK NY 10019
Hugin Robert J director C/O THE MEDICINES CO 8 CAMPUS DR PARSIPPANY NJ 07054
Heffernan Michael Thomas director C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Stock Elyse officer: Chief Medical Officer 215 CHURCH STREET NEW HAVEN CT 06510
Jones William A Jr officer: CCO-Migraine & Common Disease NITROMED, INC. 125 SPRING STREET LEXINGTON MA 02421
Repella Robert director 1410 PARSONS LANE AMBLER PA 19002
Gregory Julia P director 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Gentile Kimberly officer: VP of Operations C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Childs John W director, 10 percent owner 111 HUNTINGTON AVENUE SUITE 2900 BOSTON MA 02199
Berman Robert officer: Chief Medical Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Doogan Declan director C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Tilton John officer: Chief Commercial Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510

Biohaven Pharmaceutical Holding Co Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)